Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03345420 · ClinicalTrials.gov registry record · Phase 2
Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer
A Phase 2 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 102
- Enrollment target
NCT03345420 is a Phase 2 study that has completed, run by University of Utah. The registered enrollment target is 102 participants.
The verdict
NCT03345420, a Phase 2 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 102 participants
- Enrollment target
Study Summary
This phase II trial studies how well hypofractionated radiation therapy works in treating patients with stage 0-IIB breast cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
Interventions
- RADIATION Hypofractionated Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2025-06-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03345420
The ClinicalTrials.gov registry entry for NCT03345420 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypofractionated Radiation Therapy is the first listed.
NCT03345420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03345420 about?
NCT03345420 is a clinical study titled "Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer". This phase II trial studies how well hypofractionated radiation therapy works in treating patients with stage 0-IIB breast cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.
What is the current status of trial NCT03345420?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 102 participants. The study started on 2017-12-12. Estimated completion is 2025-06-26.
What interventions are being tested in trial NCT03345420?
The interventions under investigation include: Hypofractionated Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT03345420?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.